Indexed rent reviews continue to drive earnings growth and property valuation uplifts at  Target Healthcare REIT Ltd (THRL) . Meanwhile,...

Basilea Pharmaceutica  has continued its strong momentum into 2025, announcing the receipt of a CHF1.2m milestone payment for Cresemba...

H224 continues to be a rewarding period for  Basilea Pharmaceutica , with the announcement of a third successive milestone payment for...

Basilea Pharmaceutica ’s H124 results reflect strong momentum across its pipeline and  Edison Group  expects the pace to accelerate in...

The uptrend in Cresemba sales in Asia-Pacific and China triggered the receipt of  Basilea Pharmaceutica ’s third milestone payment of...

SIGA Technologies  announced another contract win with the US Department of Defense (DoD), which is for the procurement of c $9m in...

Basilea Pharmaceutica has announced an asset purchase agreement with the Glioblastoma Foundation for lisavanbulin (BAL101553), the...

ALG Newsletter - Can we make NHI more affordable? We look at the signing of the NHI Bill from a slightly different perspective. Can...

Basilea Pharmaceutica has announced the triggering of a US$1.25m milestone payment from Pfizer, triggered by sustained strong sales of...

In the lead up to its capital markets day, Basilea Pharmaceutica announced it has received initial funding of up to US$0.9m through a...

SIGA Technologies announced a strategic step in fortifying its distribution partner, Meridian, allowing greater control over planning and...

Basilea Pharmaceutica has announced the FDA approval of its second lead asset, Zevtera (ceftobiprole), for the treatment of severe...